SUGAMMADEX LAPL sugammadex (as sodium) 200 mg/2 mL solution for injection vial - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
SUGAMMADEX LAPL sugammadex (as sodium) 200 mg/2 mL solution for injection vial
AUST R: 395864
Active ingredients:
sugammadex sodium

Dosage form:
Injection

Sponsor:
Lupin Australia Pty Limited

Phone:
03 9809 7999

Deletion from market:
31 Jan 2027

Shortage status:
To be discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

Management action:
Alternative brands are available.